Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Latest filing published 20 Jun 2025 for Kronos Bio, Inc., €69k.
Filing timeline
BuySaleDeborah Knobelman
Insider track record
Disclosed buys
0
Disclosed sells
1
Signal history
Deborah Knobelman: trading record in brief
Deborah Knobelman has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Kronos Bio, Inc. and Senti Biosciences Holdings, Inc. The record holds 5 filings, for trades running from 3 October 2022 to 20 June 2025.
The open-market record consists of 1 sale worth €19k, with no purchase. The rest of the record consists of 3 share grants. 2025 to date brings no purchases and 1 sale.
The newest entry dates from 20 June 2025: a transaction of €69k, in Kronos Bio, Inc. Typically, a trade is published a median of 1 day after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Deborah Knobelman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
139,422 shares@ US$0.5778.6% of flowCommon StockSEC:0001415889-25-017823:0
24,838 shares@ US$0.867821.4% of flowCommon StockSEC:0001415889-25-016003:0
164,260 shares0Common StockSEC:0001415889-24-015398:0
101,000 shares0Common StockSEC:0001854270-24-000013:0
30,000 shares0Common StockSEC:0001854270-22-000036:0
5 of 5 declarations
